Prof. Andreana Haley from the University of Texas at Austin (UT Austin), the USA presented a lecture on the connection between brain and health entitled Clinical Neuroscience - Connecting Body and Brain Health. It was held on 16th April at the Faculty of Pharmacy of MU-Varna. The topic was intended for students involved in the elective course "Molecular Biology in Medicine", Bulgarian- and English-Language Training, and for everyone interested in Medicine, Psychology, Biomedical Technology, and Healthy Living. The event was organised under project BG-RRP-2.004-0009-C02 Enhancement of Translational Excellence Achievement in Medicine (MUVE-TEAM), funded by the European Union–NextGenerationEU.
Business card: Prof. Andreana Haley is a graduate of the First Language High School - Varna. She is a Professor of Clinical Psychology at the University of Texas at Austin and Director of the UT Clinical Neuroscience Lab at the institution. She was awarded PhD degree in Clinical Psychology from the University of Virginia in 2005 after completing a pre-doctoral fellowship in Neuropsychology and Rehabilitation Medicine at Eastern Virginia Medical School.
Prior to joining the Clinical Psychology Faculty at UT Austin, she spent two years as a Research Fellow in dementia at Brown University and as a Visiting Scholar at the Neuroimaging Centre at Brigham and the Women's Hospital in Boston. Her area of research interest is related to exploring the biological basis of cognitive impairment associated with ageing and dementia. As a clinical neuropsychologist, Prof. Haley is focused on investigating the neural substrates of memory, language, and executive function in clinical populations, in vivo, using functional neuroimaging (fMRI) and neurospectroscopy (1H MRS).
Prof. Haley is also working on determining how disturbances in glucose metabolism, hormonal regulation, and cardiovascular function contribute to changes in cognitive abilities, brain morphology, and energy metabolism. Her ambition is to bridge the gap between fundamental and clinical neuroscience in order to ultimately improve the way we understand, predict, and treat age- and disease-related cognitive impairment.
